Market Place
Sourcing Support
Xiamen`s Generics Topiramate Receives Approval in US
05 Nov 2024 //
FDA
Senores`s Generics Topiramate Receives Approval in US
10 Oct 2024 //
FDA
Glenmark Pharma gets USFDA nod for seizure treatment drug
17 Jul 2024 //
MONEYCONTROL
Alkem Labs Generic Topiramate Receives Approval in US
13 Jun 2024 //
FDA
Xiamen LP Generic Topiramate Receives Tentative Approval Approval in U.S.
12 Apr 2024 //
FDA
Torrent Pharma`s Generic Topiramate Receives Tentative Approval in the U.S.
10 Apr 2024 //
FDA
Ligand Announces New Topiramate Data Presented at the Conference
08 Apr 2024 //
BUSINESSWIRE
Enforcement Report - Week of January 10, 2024
10 Jan 2024 //
FDA
Dr. Reddy`s Generic Topiramate Receives Approval in the U.S.
17 Nov 2023 //
FDA
Ajanta Pharma`s Generic Topiramate Receives Approval in the U.S.
15 Aug 2023 //
FDA
Par`s Generic Topiramate Receives Receives Approval in the U.S.
04 May 2023 //
FDA
Zydus launches Topiramate Extended-Release Capsules for epilepsy
06 Jan 2023 //
ECONOMICTIMES
QSYMIA (Phentermine-Topiramate) Drug Insights and Market Forecasts to 2032
03 Jan 2023 //
PR NEWSWIRE
Zydus` Generic Topiramate Receives Approval in the U.S.
28 Nov 2022 //
FDA
Gynecological Drugs Restricted In EU; Safety Review Starts For Pholcodine
05 Sep 2022 //
PINK SHEETS
PRAC starts review of topiramate use in pregnancy and women of childbearing
02 Sep 2022 //
EMA
ICER reaffirms Qsymia as most cost-effective obesity treatment in final report
31 Aug 2022 //
ENDPTS
FDA Approves Qsymia for Treating Teens With Obesity
29 Jun 2022 //
MEDSCAPE
Ajanta Pharma GenericTopiramate Receives Approval in the U.S.
09 Jun 2022 //
FDA
Enforcement Report - Week of December 1, 2021
01 Dec 2021 //
FDA
FDA approves Eton-Azurity’s Eprontia oral solution for seizures and migraines
09 Nov 2021 //
PHARMACEUTICAL-TECHNOLOGY
Aimovig displays superiority over topiramate in migraine study
09 Nov 2021 //
EUROPEANPHARMACEUTICALREVIEW
Eton Pharma and Azurity Pharmaceuticals, Inc. Announce FDA Approval of EPRONTIA™
08 Nov 2021 //
GLOBENEWSWIRE
AZURITY ANNOUNCES FDA APPROVAL OF EPRONTIA oral solution
08 Nov 2021 //
PRNEWSWIRE
Ascent Pharms`s Generic Topiramate Receives Approval in the US
26 Aug 2021 //
FDA
Glenmark Pharms` Generic Topiramate Receives Approval in US
06 Feb 2021 //
FDA
Glenmark receives ANDA approval for Topiramate Extended-release Capsules
03 Feb 2021 //
PRNEWSWIRE
Eton Announces Acceptance for Filing of NDA for Topiramate Oral Solution
17 Dec 2020 //
NASDAQ
Eton Announces Acceptance for Filing of NDA for Topiramate Oral Solution
17 Dec 2020 //
NASDAQ
Novartis’ Aimovig tops topiramate in migraine face-off
05 Nov 2020 //
PHARMAPHORUM
Eton Pharmaceuticals Reports Positive Study Results for ET-101
17 Mar 2020 //
GLOBE NEWSWIRE
Dr. Reddy`s Laboratories announces the launch of Ziprasidone Mesylate
17 Mar 2020 //
BUSINESSWIRE
Fighting obesity by attacking both food intake and energy burn
29 Jun 2019 //
FIERCE BIOTECH
In another misstep for Vivus, FDA`s promo police ding misleading Qsymia webpage
07 Jun 2019 //
FIERCE PHARMA
OPDP Issues Second Untitled Letter of 2019
30 May 2019 //
RAPS
Glenmark Pharma gets USFDA nod for seizure treatment drug
25 Jan 2019 //
BUSINESSWIRE
Glenmark Pharm`s Generic Topiramate Receives Tentative Approval in US
22 Jan 2019 //
FDA
Par Pharma`s Generic Topiramate Receives Tentative Approval in US
25 Sep 2018 //
FDA
Supernus Pharma to Buy Biscayne Neurotherapeutics in Potential $183 Million Deal
15 Sep 2018 //
BIOSPACE
UC San Diego researchers uncover root of leptin resistance
24 Aug 2018 //
ENDPTS
With debt looming, browbeaten diet pill maker Orexigen goes bankrupt
13 Mar 2018 //
ENDPTS
Zydus Pharms USA’s Generic Topiramate Receives Approval In US
29 Nov 2017 //
FDA
New migraine results for both Allergan and Novartis
11 Sep 2017 //
PHARMA TIMES
Upsher-Smith Launches Newly Designed Website For Qudexy® XR (topiramate)
22 Aug 2017 //
PR NEWSWIRE
FDA Approves Expanded Indication for Qudexy topiramate Extended-Release Capsules
30 Mar 2017 //
PR NEWSWIRE
Cadila inks pact with Supernus Pharma to settle patent issue
08 Mar 2017 //
ECONOMIC TIMES
Topiramate Extended-Release Options: A Focus onEfficacy and Safety in Epilepsy
07 Mar 2017 //
PHARMA-EXCIPIENTS
Supernus Wins Appeal Case on Oxtellar XR®
12 Dec 2016 //
GLOBENEWSWIRE
Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine
08 Nov 2016 //
PHARMA EXCIPIENTS
Upsher-Smith Launches
08 Sep 2016 //
PR NEWSWIRE
Upsher-Smith Granted Tentative FDA Approval For Qudexy XR (topiramate)
09 Jun 2016 //
PR NEWSWIRE
Future obesity drugs must provide improved efficacy & safety,says GBI Research
17 Dec 2015 //
CPHI-ONLINE
Vivus counts $25M in Q3 sales, $300M in debt
05 Nov 2015 //
FIERCE PHARMA
Icahn casts his eye on Vivus with tender offer for convertible notes
09 Sep 2015 //
FIERCE PHARMA
Brutal honesty in drug marketing? For obesity meds, it`s key to avoiding the `magic pill` trap
09 Jun 2015 //
FIERCE PHARMA MARKETING
Eisai predicts long-awaited operating profit rise for fiscal 2015
15 May 2015 //
FIERCE PHARMA
Vivus Files Lawsuit Against Teva For Infringement Of Qsymia Patents
16 Apr 2015 //
EIN NEWSDESK
Upsher Smith`s Qudexy XR (Topiramate) Approved in USA For Seizures
04 Apr 2015 //
FDA
